triazoles has been researched along with Mouth Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hiraki, A; Hirosue, A; Kawahara, K; Matsuoka, Y; Nagao, Y; Nagata, M; Nakamoto, M; Nakao, M; Nakayama, H; Saitoh, N; Sakata, J; Shinohara, M; Takahashi, N; Yamamoto, T; Yoshida, R | 1 |
Alvarez Abreu, P; Cardozo Paes de Almeida, E; Carolina Carvalho da Fonseca, A; Cavalcanti Chipoline, I; de Carvalho da Silva, F; de Queiroz, LN; Francisco Ferreira, V; Luiz Ferraz de Souza, T; Pereira de Souza, M; Pontes, B; Ribeiro Machado da Costa, G; Robbs, BK; Won-Held Rabelo, V | 1 |
Hayashi, K; Onda, T; Onidani, K; Sekikawa, S; Shibahara, T; Shiraishi, N; Watanabe, K | 1 |
Han, G; Li, W; Li, X; Yang, B | 1 |
Allegri, L; Baldan, F; Catia, M; Damante, G; Lazarevic, M; Milasin, J; Milosevic, M | 1 |
Huang, P; Li, Q; Liu, X; Tong, D; Wu, H; Zhang, F | 1 |
Chelvanambi, M; Fabian, KPL; Hong, CS; Lang, S; Ludwig, S; Razzo, BM; Storkus, WJ; Whiteside, TL | 1 |
Huang, P; Lv, Z; Qi, Y; Wang, L; Wei, X; Wu, X; Yang, P; Zhang, F | 1 |
Andreadis, D; Antoniades, D; Arsenis, G; Belazi, M; Destouni, E; Eliopoulou, C; Hini, S; Koussidou-Eremondi, T; Velegraki, A | 1 |
9 other study(ies) available for triazoles and Mouth Neoplasms
Article | Year |
---|---|
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Topics: Animals; Azepines; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Lymphatic Metastasis; Male; Matrix Metalloproteinase 2; Mice; Mouth Neoplasms; Prognosis; Transcription Factors; Triazoles | 2020 |
Molecular mechanism of action of new 1,4-naphthoquinones tethered to 1,2,3-1H-triazoles with cytotoxic and selective effect against oral squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Humans; Mice; Molecular Structure; Mouth Neoplasms; Naphthoquinones; Triazoles | 2020 |
Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells.
Topics: Adult; Aged; Aged, 80 and over; Animals; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Male; Middle Aged; Molecular Targeted Therapy; Mouth Mucosa; Mouth Neoplasms; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Triazoles | 2021 |
The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Proliferation; Dinoprostone; Humans; Mouth Neoplasms; Receptors, Prostaglandin E, EP4 Subtype; Thiophenes; Triazoles; Tumor Cells, Cultured | 2017 |
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells.
Topics: Antineoplastic Agents; Azepines; Benzodiazepines; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Mouth Neoplasms; Neoplastic Stem Cells; Triazoles | 2019 |
EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
Topics: Aminopyridines; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Azepines; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Female; Gene Knockdown Techniques; Humans; Mice; Morpholines; Mouth Neoplasms; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Cisplatin; Combined Modality Therapy; Female; Immunotherapy; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Neoplasms, Experimental; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Triazines; Triazoles; Vaccines, Subunit | 2019 |
JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Azepines; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Nuclear Proteins; Polymerase Chain Reaction; Squamous Cell Carcinoma of Head and Neck; Transcription Factors; Triazoles | 2016 |
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Topics: Adult; Aged; Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Carcinoma, Squamous Cell; Cranial Irradiation; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Pyrimidines; Stomatitis; Triazoles; Voriconazole | 2004 |